STOCK TITAN

ADMA Biologics, Inc. (ADMA) Net Income by Year

ADMA

ADMA Biologics, Inc. reported $146.9M in net income in fiscal year 2025. This represents a decrease of 25.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $169.0M in net income. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters ADMA Biologics, Inc. has filed alongside them.

FY2025 annual
Net Income $146.9M
YoY -25.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ADMA Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income$169.0M$146.9M-25.7%$197.7M+801.1%-$28.2M+57.2%-$65.9M+8.0%-$71.7M+5.4%-$75.7M-56.9%-$48.3M+26.6%-$65.7M-50.2%-$43.8M-124.2%-$19.5M-8.6%-$18.0M-6.9%-$16.8M-8.3%-$15.5M-112.7%-$7.3M-23.7%-$5.9M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

ADMA Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income$37.8M+10.5%$45.3M+68.5%$49.4M-55.9%$36.4M+1.4%$34.2M+6.7%$26.9M+51.1%$111.9M+735.7%$35.9M+1300.0%$32.1M+603.2%$17.8M+362.3%-$17.6M-44.0%$2.6M+117.2%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More ADMA Biologics, Inc. financials

Frequently Asked Questions

What was ADMA Biologics, Inc.'s net income in fiscal year 2025?

ADMA Biologics, Inc. reported $146.9M in net income in fiscal year 2025.

How fast is ADMA Biologics, Inc.'s net income growing?

ADMA Biologics, Inc. (ADMA) net income fell by 25.7% year over year, from $197.7M to $146.9M in fiscal year 2025.

What is ADMA Biologics, Inc.'s net income over the last twelve months?

ADMA Biologics, Inc. (ADMA) reported $169.0M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, ADMA Biologics, Inc. (ADMA) net income went from -$5.9M in fiscal year 2011 to $146.9M in fiscal year 2025.

ADMA Biologics, Inc. (ADMA) reported $37.8M in net income in Q2 2026. This represents an increase of 10.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what ADMA Biologics, Inc. (ADMA) reported on that line in every period on record.